| ANG-2 | Angiopoietin-2 |
| BC | Breast cancer |
| CRC | Colorectal cancer |
| CTLA-4 | Cytotoxic T-lymphocyte associated protein 4 |
| CXCL10 | CXC-chemokine ligand 10 |
| CXCR3+ | C-X-C motif chemokine receptor 3 |
| DC | Dendritic cells |
| EMA | European Medial Agency |
| FGF | Fibroblast growth factor |
| FLT3 | Fms-like tyrosine kinase-3 receptor |
| HCC | Hepatocellular carcinoma |
| HIF-1 | Hypoxia-inducible factor 1 |
| HSPG | Heparan sulfate proteoglycans |
| ICAM1 | Intracellular adhesion molecule 1 |
| MAPK | Mitogen-activated protein kinase |
| MC | Mast cells |
| MDSC | Myeloid-derived suppressor cell |
| MMP-9 | Metallopeptidase 9 |
| NF-κB | Nuclear factor-kappa B |
| NK | Natural killer |
| NRP | Neuropilin |
| NSCLC | Non-small cell lung cancer |
| OC | Ovarian cancer |
| OS | Overall survival |
| PD-1 | Programmed cell death 1 |
| PDGF | Platelet-derived growth factor |
| PFS | Progression-free survival |
| PI3K | Phosphoinositide-3-kinase |
| PKB | Protein kinase B |
| PKC | Protein kinase C |
| PLCγ | Phospholipase-Cγ |
| PlGF | Placental growth factor |
| RCC | Renal cell carcinoma |
| SCC | Squamous cell carcinoma |
| TAM | Tumor-associated macrophage |
| TGF-β | Transforming growth factor β |
| TIM-3 | T cell immunoglobulin and mucin-domain containing-3 |
| TKI | Tyrosine kinase inhibitors |
| TME | Tumor microenvironment |
| TNFα | Tumor necrosis factor-α |
| VCAM1 | Vascular cell adhesion protein 1 |
| VEGF | Vascular endothelial growth factor |
| VEGFR | Vascular endothelial growth factor receptors |